- Home
- PL vs BCRX Comparison
PL vs BCRX Comparison
Compare PL & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PL
- BCRX
- Stock Information
- Founded
- PL 2010
- BCRX 1986
- Country
- PL United States
- BCRX United States
- Employees
- PL N/A
- BCRX N/A
- Industry
- PL Aerospace
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PL Industrials
- BCRX Health Care
- Exchange
- PL Nasdaq
- BCRX Nasdaq
- Market Cap
- PL 1.3B
- BCRX 1.5B
- IPO Year
- PL N/A
- BCRX 1994
- Fundamental
- Price
- PL $4.67
- BCRX $7.61
- Analyst Decision
- PL Strong Buy
- BCRX Buy
- Analyst Count
- PL 9
- BCRX 6
- Target Price
- PL $4.34
- BCRX $15.17
- AVG Volume (30 Days)
- PL 4.3M
- BCRX 2.2M
- Earning Date
- PL 12-09-2024
- BCRX 02-24-2025
- Dividend Yield
- PL N/A
- BCRX N/A
- EPS Growth
- PL N/A
- BCRX N/A
- EPS
- PL N/A
- BCRX N/A
- Revenue
- PL $241,650,000.00
- BCRX $412,579,000.00
- Revenue This Year
- PL $14.34
- BCRX $38.44
- Revenue Next Year
- PL $12.08
- BCRX $21.23
- P/E Ratio
- PL N/A
- BCRX N/A
- Revenue Growth
- PL 12.49
- BCRX 29.92
- 52 Week Low
- PL $1.67
- BCRX $4.03
- 52 Week High
- PL $4.99
- BCRX $8.88
- Technical
- Relative Strength Index (RSI)
- PL 64.65
- BCRX 50.40
- Support Level
- PL $3.76
- BCRX $6.96
- Resistance Level
- PL $4.03
- BCRX $8.02
- Average True Range (ATR)
- PL 0.26
- BCRX 0.45
- MACD
- PL -0.01
- BCRX -0.04
- Stochastic Oscillator
- PL 92.98
- BCRX 42.48
About PL Planet Labs PBC
Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.